glp 1 with ulcerative colitis Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology

GLP-1 Benefits For People With Ulcerative Colitis and Obesity

26.39

★★★★☆4.8 (126)

A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation

26.01

★★★★★4.9 (98)

Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway | Naunyn-Schmiedeberg's Archives of Pharmacology

28.37

★★★★★5.0 (157)

Ulcerative colitis and GLP-1 medications are a major focus for scientists right now. Here's what's happening: between 2024 and 2025, at least six studies have been published in respected journals like Oxford

29.80

★★★★★4.7 (84)

GLP-1R agonists modulate ulcerative colitis risk. New research alert! Using #Multiomics MR, colocalization, #Epigenomics, #RNAseq, and #scRNAseq analyses, this study demonstrates that GLP-1R agonists modulate ulcerative colitis risk by driving specific

26.02

★★★★★4.9 (203)

New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications

29.01

★★★★★5.0 (176)

GLP-1RAs for IBD

28.70

★★★★★4.8 (132)